We demonstrated that both DNI and CRP levels were significantly higher in the DCM group compared with the control group, that these two markers were particularly elevated in the poor-prognosis subgroup with EF ≤ 20%, and that DNI was independently associated with mortality. Here, CRP is linked to familial dilated cardiomyopathy.